公开(公告)号：US20220259320A1

公开(公告)日：2022-08-18

申请号：US17682922

申请日：2022-02-28

Applicant: PROMETHEUS BIOSCIENCES, INC. ,  CEDARS-SINAI MEDICAL CENTER

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  Rafael Rojas ,  Matthew Reissman ,  Patricia McNeeley ,  Janine Bilsborough ,  Bradley Henkle ,  Stephan R. Targan

IPC: C07K16/28 ,  A61P1/04 ,  C07K16/24

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US11999789B2

公开(公告)日：2024-06-04

申请号：US17682922

申请日：2022-02-28

Applicant: PROMETHEUS BIOSCIENCES, INC. ,  CEDARS-SINAI MEDICAL CENTER

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  Rafael Rojas ,  Matthew Reissman ,  Patricia McNeeley ,  Janine Bilsborough ,  Bradley Henkle ,  Stephan R. Targan

IPC: C07K16/24 ,  A61P1/04 ,  C07K16/28 ,  A61K39/395 ,  C07K14/52 ,  C07K14/525

CPC classification number: C07K16/2875 ,  A61P1/04 ,  C07K16/241 ,  C07K2317/21 ,  C07K2317/24 ,  C07K2317/40 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/56 ,  C07K2317/76

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US20240327532A1

公开(公告)日：2024-10-03

申请号：US18645261

申请日：2024-04-24

Applicant: PROMETHEUS BIOSCIENCES, INC. ,  CEDARS-SINAI MEDICAL CENTER

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  Rafael Rojas ,  Matthew Reissman ,  Patricia McNeeley ,  Janine Bilsborough ,  Bradley Henkle ,  Stephan R. Targan

IPC: C07K16/28 ,  A61P1/04 ,  C07K16/24

CPC classification number: C07K16/2875 ,  A61P1/04 ,  C07K16/241 ,  C07K2317/21 ,  C07K2317/24 ,  C07K2317/40 ,  C07K2317/51 ,  C07K2317/515 ,  C07K2317/56 ,  C07K2317/76

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US11292848B2

公开(公告)日：2022-04-05

申请号：US17110004

申请日：2020-12-02

Applicant: PROMETHEUS BIOSCIENCES, INC. ,  CEDARS-SINAI MEDICAL CENTER

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  Rafael Rojas ,  Matthew Reissman ,  Patricia McNeeley ,  Janine Bilsborough ,  Bradley Henkle ,  Stephan R. Targan

IPC: C07K16/24 ,  C07K16/28 ,  A61P1/04 ,  C07K14/52 ,  C07K14/525 ,  A61K39/395

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US20210122828A1

公开(公告)日：2021-04-29

申请号：US17110004

申请日：2020-12-02

Applicant: PROMETHEUS BIOSCIENCES, INC.

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  Rafael Rojas ,  Matthew Reissman ,  Patricia McNeeley

IPC: C07K16/28 ,  A61P1/04

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).